Software uncovers link between childhood maltreatment and higher risk of rheumatoid arthritis or psoriasis in later life
University of Birmingham venture Dexter has demonstrated the power of its Dexter software platform in a study showing that ...
Everyday Health4d
Rheumatoid Arthritis Rashes: What You Need to Know
Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...
rheumatologyadvisor1d
Bidirectional Association Found Between Rheumatoid Arthritis, COPD
There is a bidirectional association between rheumatoid arthritis (RA) and chronic obstructive pulmonary disease (COPD).
rheumatologyadvisor18h
More Than Half of People With Rheumatoid Arthritis Have Anemia
HealthDay News — Anemia is prevalent among patients with rheumatoid arthritis (RA), according to a study published online Oct. 26 in Cureus. Jamal Shah, M.B.B.S., from Khyber Teaching Hospital in ...
Endocrinology Advisor2d
Patients With Rheumatoid Arthritis Face Higher COVID-19 Risks
Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...
Too Old to Operate2d
Relationships between genetic polymorphisms of IL-1β and rheumatoid arthritis.
This study aimed to investigate the association between the interleukin-1 beta (IL-1β) gene polymorphism (rs2853550) and the risk of rheumatoid arthritis (RA) in a sample of the Iraqi population. The ...
clinicalpainadvisor.com4d
Higher Adalimumab Trough Levels Improve Outcomes in Rheumatoid Arthritis
Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...
Healio5d
Ivarmacitinib curbs rheumatoid arthritis symptoms, improves function through 52 weeks
A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...
Medscape1d
Monoclonal Antibodies in Rheumatoid Arthritis
Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...